These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5496809)

  • 1. Effect of sirepar on experimental cirrhosis in rats.
    Szarvas F; Biliczki F
    Ther Hung; 1970; 18(3):103-6. PubMed ID: 5496809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study of the therapeutic effect of interferon-alpha on liver fibrosis].
    Huang Y; Wang C; Li S; Zhou M
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):71. PubMed ID: 11856515
    [No Abstract]   [Full Text] [Related]  

  • 3. Sirepar in the treatment of hepatic cirrhosis and its effect on autoantibody levels.
    Fassati P; Fassati M; Horejsí J; Jezková Z
    Tijdschr Gastroenterol; 1974; 17(4):259-66. PubMed ID: 4462729
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic study an extract of hepatolysate].
    Gmaz-Nikulin E; Radović N
    Med Arh; 1966; 20(1):15-20. PubMed ID: 5958972
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigations on the effect of liver preparations.
    Magyar I
    Acta Med Acad Sci Hung; 1968; 25(3):323-30. PubMed ID: 5720863
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of compensated hepatopathies using Sirepar and Ripason].
    Fassati P; Fassati M
    Cas Lek Cesk; 1967 Oct; 106(43):1143-50. PubMed ID: 6077099
    [No Abstract]   [Full Text] [Related]  

  • 7. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
    Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological substantiation of treatment of liver cirrhosis with retabolil].
    Riabinina NE; Markov RM
    Farmakol Toksikol; 1976; 39(5):625-7. PubMed ID: 1028594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on the antihepatotoxic effect of a liver extract as illustrated in the model of a rat liver damaged by carbon tetrachloride].
    Pappas A; Schwarze G; Veleris-Triandafyllou J
    Med Welt; 1974 Jan; 25(4):150-2. PubMed ID: 4822929
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential gene expression profiles in the steatosis/fibrosis model of rat liver by chronic administration of carbon tetrachloride.
    Chung H; Hong DP; Kim HJ; Jang KS; Shin DM; Ahn JI; Lee YS; Kong G
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):242-54. PubMed ID: 16239168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty cirrhosis in the rat.
    Zaki GF
    Arch Pathol; 1966 Jun; 81(6):536-43. PubMed ID: 5934088
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the effect of a liver hydrolysate on the hepatic circulation in chronic liver diseases.
    Obayashi A; Akioka H; Tazaki H
    Arzneimittelforschung; 1972 Mar; 22(3):578-80. PubMed ID: 5067932
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrogenesis in rat liver injured by carbon tetrachloride. An immunohistochemical study.
    Yanagisawa T; Takuma S; Sawada T; Watanabe K; Watanabe K
    Bull Tokyo Dent Coll; 1982 Feb; 23(1):1-8. PubMed ID: 6955067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Green tea extracts protected against carbon tetrachloride-induced chronic liver damage and cirrhosis].
    Xiao J; Lu R; Shen X; Wu M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jul; 36(4):243-6. PubMed ID: 12411204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of metabonomics on an experimental model of fibrosis and cirrhosis induced by thioacetamide in rats.
    Constantinou MA; Theocharis SE; Mikros E
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):11-9. PubMed ID: 17113614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stephania tetrandra prevents and regresses liver fibrosis induced by carbon tetrachloride in rats.
    Chor JS; Yu J; Chan KK; Go YY; Sung JJ
    J Gastroenterol Hepatol; 2009 May; 24(5):853-9. PubMed ID: 19220659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of glycyrrhetinic acid and IFN-alpha on HSCs collagen metabolism in rat fibrotic liver of varying stages].
    Zhang Q; Wang J; Hu M
    Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):72-3. PubMed ID: 11856516
    [No Abstract]   [Full Text] [Related]  

  • 19. TNF-alpha as therapeutic target in NASH: tried, but not yet proven.
    Chitturi S; Farrell GC
    J Gastroenterol Hepatol; 2007 May; 22(5):613-4. PubMed ID: 17444846
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental siderosis and liver injury in the rhesus monkey.
    Nath I; Sood SK; Nayak NC
    J Pathol; 1972 Feb; 106(2):103-11. PubMed ID: 4624689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.